These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10693067)

  • 1. Identifying and screening patients at high risk of colorectal cancer in general practice.
    House W; Sharp D; Sheridan E
    J Med Screen; 1999; 6(4):205-8. PubMed ID: 10693067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colonoscopy for early detection of colorectal cancer in average-risk population].
    Niv Y; Brenner B; Fireman Z; Fraser G; Gal E; Levy Z
    Harefuah; 2006 Nov; 145(11):841-2. PubMed ID: 17183959
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic.
    Houlston RS; Murday V; Harocopos C; Williams CB; Slack J
    BMJ; 1990 Aug 18-25; 301(6748):366-8. PubMed ID: 2169322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
    Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
    BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.
    Winawer SJ; Zauber AG; Ho MN; O'Brien MJ; Gottlieb LS; Sternberg SS; Waye JD; Schapiro M; Bond JH; Panish JF
    N Engl J Med; 1993 Dec; 329(27):1977-81. PubMed ID: 8247072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation.
    Ferrández A; Navarro M; Díez M; Sopena F; Roncalés P; Polo-Tomas M; Sáinz R; Lanas A
    Endoscopy; 2010 Dec; 42(12):1071-6. PubMed ID: 20960390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal occult blood testing for colorectal cancer in general practice.
    Million R; Howarth J; Turnberg E; Turnberg LA
    Practitioner; 1982 Apr; 226(1366):659-63. PubMed ID: 7088857
    [No Abstract]   [Full Text] [Related]  

  • 10. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
    Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
    Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
    Strul H; Elyakim R; Halpern Z; Arber N
    Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colon cancer.
    Heiken JP
    Cancer Imaging; 2006 Oct; 6(Spec No A):S13-21. PubMed ID: 17114066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colorectal cancer screening: a survey of French general practitioners].
    Denis B; Perrin P; Cailleret AF; Guth F; Ruetsch M; Strentz P
    Gastroenterol Clin Biol; 2003 Nov; 27(11):992-7. PubMed ID: 14732845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial risk of colorectal cancer in subjects attending an organised screening programme.
    Castiglione G; Visioli CB; Zappa M; Grazzini G; Mallardi B; Mantellini P
    Dig Liver Dis; 2012 Jan; 44(1):80-3. PubMed ID: 21925983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge of colorectal cancer and use of screening tests among higher-risk persons.
    Polednak AP
    J Cancer Educ; 1990; 5(2):115-24. PubMed ID: 2206933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
    Weber MF; Banks E; Ward R; Sitas F
    J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.